We then evaluated the viability of the spheroid generated from NSCLC-related MPE after gefitinib treatment by using this modified MTT assay as it can be more easily adopted in clinical practice than immunofluorescence staining of cleaved caspase 3. Here, CASP3 is linked to non-small cell lung carcinoma.